Pharma Sust 300 is a high-concentration injectable testosterone blend formulated to combine short, intermediate, and long-acting esters for sustained hormonal optimization.
Active Formulation Concentration: 300 mg/mL Format: Multi-dose injectable oil solution (typically supplied in a 10 mL vial). Primary Manufacturer Identity:Pharmacom Labs (Trade designation: PHARMA SUST 300).
Molecular Composition & Dual-Phase Kinetics
Pharma sust 300 is an advanced, high-concentration modification of the classical multi-ester Sustanon compound. It is formulated utilizing micro-synthesis protocols to pack 300 mg of total testosterone active agent per single milliliter—representing a 20% higher active concentration than standard 250 mg legacy blends.
The preparation balances four unique testosterone esters bound to the natural testosterone molecule, allowing it to provide an immediate release phase paired with an elongated metabolic trail:
Testosterone Propionate (36 mg): Fast-acting short chain. Delivers an immediate physiological surge within 24 to 48 hours post-administration.
Testosterone Phenylpropionate (72 mg): Rapid-to-intermediate release ester adding consistent hormone presence after the initial peak.
Testosterone Isocaproate (72 mg): Intermediate-release profile to maintain stable systemic saturation levels as short esters clear.
Testosterone Decanoate (120 mg): Heavy, extended long-chain ester that trickles active compounds slowly into circulation, extending total therapeutic activity for up to 10 to 14 days.
Documented Clinical and Physiological Effects
Anabolic Support: Significantly enhances protein synthesis and systemic nitrogen retention, facilitating the rapid accretion and preservation of lean muscle tissues.
Hormonal Optimization: Clinically used under controlled parameters to treat male hypogonadism (clinical testosterone deficiency) to restore standard baseline libido, energy reserves, and metabolic immunity.
Hematological and Structural Support: Promotes enhanced erythropoiesis (red blood cell production) to optimize oxygen transportation capabilities, while assisting bone mineralization to stave off osteoporotic degradation.
Reviews
There are no reviews yet.
Be the first to review “Pharma Sust 300”Cancel Reply
Reviews
There are no reviews yet.